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Abstract:  Background: Cancer 
remains a major cause of death in 
children and adolescents, and dif-
fers in adults in nature, distribu-
tion and prognosis1. A culture of 
case documentation is lacking in 
our environment and many cases 
go unreported. 
Study objectives: To document the 
pattern of childhood and adoles-
cent malignancies at a tertiary 
health institution in south-east 
Nigeria over a ten year period 
(January 2004 to December 2013) 
Methodology: Details of all chil-
dren and adolescents aged 18 
years and below treated for malig-
nancy were extracted from the 
cancer registry and the records 
unit of the histopathology depart-
ment for the period beginning at 
January 2004 to December 2013 
at Nnamdi Azikiwe University 
Teaching Hospital (NAUTH), 
Nnewi, Nigeria. Information re-
trieved was verified against the 
hospital admission register, as 
well as the medical and histopa-
thology records for all cancer pa-
tients over the period of interest. 
Results: Eighty-five cases of 
childhood and adolescent  
malignancy were treated at 
NAUTH, Nnewi between Janu-
ary2004 and December 2013. Me-
dian age of the study population 
was 9years, with a range of 0.1– 
18years, more males (56.50%) 
than females (43.50%). Common-
est tumours were the Lymphomas 
(11.76%) comprising Non-
Hodgkin’s lymphoma (80%), 
Hodgkin’s lymphoma (10%) and 
Large-cell lymphoma (10%), the 
Leukaemias (11.76%) comprising 
Acute myeloblastic leukaemia 
(80%) and Acute lymphoblastic 
leukaemia (20%). Others were 
Rhabdomyosarcoma (11.76%), 
Nephroblastoma (11.76%), Retino-
blastoma (5.88%), Ovarian tu-
mours (4.71%), the Soft tissue 
sarcomas-excluding rhabdomyo-
sarcoma (3.53%) and Osteogenic 
sarcoma (3.35%)’.  
Conclusion: Study findings sug-
gest that lymphoma, leukaemia, 
rhabdomyosarcoma and nephro-
blastoma are the commonest child-
hood and adolescent malignancies 






There is significant worldwide variation in the reported 
incidence of childhood cancer, which ranges from 80 to 
150 per million children2,3. Also put at 1.0 – 2.5 per 
thousand children4, childhood and adolescent cancers 
constitute approximately one percent of all cancers5. 
Annual number of new cases of childhood cancer report-
edly exceeds 200,000 worldwide, with over 80percent of 
these occurring in the developing world1. Cancer re-
mains a major cause of death in children and adoles-
cents, and differs in adults in nature, distribution and 
prognosis1. Children and adolescents in developing na-
tions are afflicted by malignancies in addition to the 
perennial problems of infectious diseases and malnutri-
tion. Data from Nigeria suggest that cancers in children 
constitute a small proportion of total admissions i pae-
diatric wards6. Also, there are observable differences in 
the incidence of childhood cancer between northern and 
southern Nigeria, with higher incidence documented in 
the south7, 8. Study findings from Kenya, Tanzaniaand 
Ghana put childhood malignancies at 0.5 to 2% of over-
all malignancies8. 
 
Linet et al (1999)9 reported leukaemia and CNS tumours 
as the commonest childhood malignancies in the United 
States, and together with skin cancers and retinoblas-
toma have shown further increase in prevalence overa 
20 year period (1975-1995). On the contrary, lympho-
mas showed a downward trend in prevalence during the 
same period. Similarly, a study report from the United 
Kingdom10 indicated a high prevalence of leukaemia 
compared with other childhood malignancies for Asian 
and Caucasian groups. However, a report11 f om a hos-
pital based study done in northern and south-west Nige-
ria put lymphomas as the commonest childhood malig-
nancy in both regions of the country, followed in north-
ern Nigeria by retinoblastoma, nephroblastoma and leu-
kaemia in descending order. In south-west Nigeria the 
prevalence of leukaemia was higher than that of retino-
blastoma11. Also, Obioha et al7 reported that lymphoma 
constituted nearly 40% of total cases of childhood ma-
lignancy in eastern Nigeria, followed by wilm’s tumour, 
leukaemia and CNS tumours in descending order. A 
high incidence of lymphoma has been reportedly associ-
ated with poor living standards7. Also, childhood cancer, 
especially leukaemia which is prevalent in high income 
countries reportedly emerges as an important cause of 
morbidity with improvement in socio-economic condi-
tions12, 13. This is so when infectious diseases and para-
sitic conditions are brought under control12, 13. 
 
In high income countries, improvement in the survival 
for children with cancer has been documented (75 - 80% 
long term survival), and is considered one of the gr at 
medical achievements of the last 50 years5. However, 
over eighty percent of cases of childhood malignancy 
live in low to middle income countries were survival for 
childhood cancer ranges from ten to thirty percent. I  
developing nations, an estimated 100,000 children di  
each year from malignancies, with no chance of a cure, 
adequate pain relief or other supportive care2,3. Poor 
outcome in low income countries may be due to late 
detection, misdiagnosis, poverty, non-availability of
drugs, co-morbidities, refusal or abandonment of treat-
ment sometimes due to superstition, as well aspoorly 
equipped health facilities4,6,11. A culture of case docu-
mentation is lacking in many developing countries and 
several cases go unreported1. Also, various environ-
mental factors negatively impact on accurate documen-
tation of childhood and adolescent malignancies, such as 
parental cultural practices, the traditional belief system, 
influence from religious bodies, and economic consid-
erations. These influence parents of affected children to 
shun conventional medical centers and resort to tradi-
tional practitioners, churches and patent medicine deal-
ers for treatment. Also, in poor resource settings, diag-
nosis of some childhood and adolescent cancers may be 
done clinically, and treatment commenced without his-
tology or cytological confirmation. These all result in 
inaccuracy of diagnosis and under reporting of malig-
nancy in this age group. The incidence of childhood an  
adolescent malignancy and assessment of disease pattern 
are best estimated from hospital archives orhistopathol-
ogy records, as there is often no reliable nationwide 
population based cancer registration5. 
 
There is the need to update and document the current 
pattern of childhood and adolescent malignancies within 
the south-east Nigerian environment. This will create 
necessary awareness among parents, medical practitio-
ners and relevant authorities about the most prevalent 
malignancies in this age group. Greater awareness 
among relevant groups will facilitate advocacy for more 
effective institutional healthcare planning and resource 
allocation for the management of the affected individu-
als in this environment. Our retrospective hospital based 
study is under taken for this purpose. The objectiv of 
this study was therefore to determine the pattern of 
childhood and adolescent malignancies at a tertiary 
health institution in south-east Nigeria over a teny ar 




Materials and Methods  
 
Using a pre-designed data sheet, details of all chidren 
and adolescents aged 18 years and below treated for 
malignancy were extracted from the cancer registry and
the records unit of the histopathology department for he 
period January 2004 to December 2013 at Nnamdi 
Azikiwe University Teaching Hospital (NAUTH), 
Nnewi, Nigeria. The information retrieved was verifi d 
against the hospital admission register obtained from the 
hospital medical records department as well as histopa-
thology records for all cancer patients over the period of 
interest. The overall age and sex distribution of the af-
fected individuals were described using percentages, and 
the relevant data displayed in tables. Inclusion criteria 
were both genders, age eighteen years and below, and 
malignant nature of tumour confirmed on histology or 
cytology. Patients with borderline histological or cyto-





Eighty-five cases of childhood malignancy confirmed on 
either histology or cytology were treated at NAUTH, 
Nnewi in the period between January 2004 and Decem-
ber 2013. The study population had an age range of 0.1 
years to 18 years, and a median age of 9 years. More 
males (56.50%) than females (43.50%) were diagnosed 
with malignancies during the study period. Table 1 
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shows the annual numbers for childhood and adolescent 
malignancies, paediatric /adolescent hospital admission  
and overall malignancies during period of study. Paedi-
atric and adolescent malignancies constituted 0.9% of 
paediatric and adolescent hospital admissions and 5.6% 
of overall malignancies treated during the same period. 
As shown in the graphical illustration (figure1), the year 
to year incidence of childhood and adolescent malign n-
cies peaked at 2.56% of hospital admissions for this age 
group in 2005, and at 7.69% and 9.35% of overall ma-
lignancies managed at NAUTH (2005 and 2012 respec-
tively). As seen in Table 2; Commonest tumours were 
the Lymphomas (11.76%) comprising Non-Hodgkin’s 
lymphoma (80%), Hodgkin’s lymphoma (10%) and 
Large-cell lymphoma (10%), the Leukaemias (11.76%) 
comprising Acute myeloblastic leukaemia (80%) and 
Acute lymphoblastic leukaemia (20%). Others include 
the Rhabdomyosarcoma (11.76%), Nephroblastoma 
(11.76%), Retinoblastoma (5.88%), Ovarian tumours 
(4.71%), the Soft tissue sarcomas-excluding rhabdomy-
osarcoma (3.53%) and Osteogenic sarcoma (3.35%). 
These are illustrated in the histogram (Fig 2). Table 2 
also shows the frequency distribution of childhood and 
adolescent malignancies in relation to patient’s gender. 
Lymphomas showed equal gender ratio (1:1),however, 
retinoblastoma and ovarian malignancies were more 
prevalent among females (ratios 2:3and 0:4 respec-
tively). More prevalent among males were leukaemia 
(3:2%), nephroblastoma(3:2%), rhabdomyosarcoma 
(7:3%), other soft tissue sarcoma (2:1%) and osteogenic 
sarcoma(2:1%). 
 
Table 1: Yearly numbers of childhood malignancies,  
paediatric /adolescent hospital admissions and overall  
malignancies and percentages  
Fig 1: Year by year number of childhood malignancies in rela-
tion to overall malignancies and paediatric/adolescent hospital 
admissions  


































2005 10 390 2.56 130 7.69 
2006 12 496 2.42 227 5.29 
2007 13 732 1.78 257 5.06 
2008 9 1818 0.50 171 5.26 
2009 6 1580 0.38 133 4.51 
2010 9 1687 0.53 156 5.77 
2011 4 928 0.42 83 4.82 
2012 10 951 0.05 107 9.35 
2013 7 458 1.53 126 5.56 
Total 85 9398 0.90 1519 5.60 
















Table 2: Paediatric malignancies and proportions in relation to 
gender  
Table 3 shows the age range and the median age for 
patients diagnosed with the commonest malignancies, 
ranging from a median age of 3 years for patients diag-
nosed with nephroblastoma and retinoblastoma, to 5.5, 
7.5, 10 and 10.5 years for rhabdomyosarcoma, leukae-
mia, ovarian malignancies and lymphoma respectively. 
Patients diagnosed with osteosarcoma and soft tissue 
sarcoma (excluding rhabdomyosarcoma) had median 
ages of 14 and 17 years respectively.  
 
Table 3: Age range and median age for patients diagnosed 






Our study findings show a peak in 2005 for new cases of 
childhood and adolescent malignancies in relation t 
paediatric and adolescent hospital admissions and the 
overall malignancies respectively. However, the chart 
also shows a reduction in the incidence of cancers in the 
Tumour  Male  Female M:F Ratio 
Nephroblastoma 6 4 3:2 
Lymphoma 5 5 1:1 
Rhabdomyosar-
coma 
7 3 7:3 
Leukaemia 6 4 3:2 
Retinoblastoma 2 3 2:3 
Ovarian Neoplasm 0 4 0:4 
Osteogenic sarcoma 2 1 2:1 
Soft tissue Sarcoma 2 1 2:1 

















Tumour Age range (yrs) Median age (yrs) 
Nephroblastoma 0.1 - 8 3 
Lymphoma 1.7 – 18 10.5 
Rhabdomyosarcoma 0.2 – 16 5.5 
Leukaemia 1.8 – 18 7.5 
Retinoblastoma 3 – 4 3 
Ovarian neoplasm 0.4 – 13 10 
Osteosarcoma 12 – 15 14 
Soft tissue sarcoma 16 - 17 17 
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subsequent half decade thereafter, and a second peak in 
2012 in relation to paediatric admissions. The first peak 
in 2005 was likely due to a generally increased parent l 
awareness about access to conventional treatment for 
childhood and adolescent malignancies at our institu-
tion.  However, the second peak in 2011 appears to cor-
respond to period of newly-introduced, improved, diag-
nostic facilities and availability of trained personnel for 
the evaluation of a variety of cancer patients, especially 
at the radiology and pathology departments of this insti-
tution.   
 
This study shows that paediatric and adolescent tumours 
constitute 5.6% of total malignancies, slightly higher 
than reported from Bangladesh (4.4%) 5 and India 
(3.58%)14, and much higher than reported in the United 
States (0.8%)15. Differences may be due to our hospital 
based data which may be unrepresentative of the true 
cancer burden, or as noted by Jabeen et al1, children and 
adolescents form a larger proportion of the population of 
developing countries due to lower life expectancy than 
in the developed world. Our study population was 
56.5% male and 43.5%female, giving a male to female 
ratio of 1.3:1, similar to the 1.5:1 reported by Agboola et 
al16 in favour of males among children diagnosed with 
malignancy in Sagamu, south-west Nigeria. However a 
gender ratio in favor of young males over females pre-
senting in hospital with cancer in the south-east Nigerian 
setting may also be reflective of the traditionally higher 
value that parents in the region place on males. 
 
This study showed that the four most common cancer 
groups in our series were tied. They were the lymphoma 
group (11.76%), comprising non-Hodgkin’s lymphoma 
(80%), Hodgkin’s lymphoma (10%) and large cell lym-
phoma (10%), and the group of Leukaemia (11.76%), 
comprising acute myeloblastic (80%) and acute lym-
phoblastic leukaemias (20%) respectively. Others are 
Nephroblastoma (11.76%)and rhabdomyosarcoma 
(11.76%). These differ from study findings thirty years 
earlier in the same region of Nigeria in1982 by Obioha 
et al7, who found a much higher proportion of lympho-
mas (40%),followed by nephroblastoma (14%), leukae-
mia (12.9%) and CNS tumours (9.7) among childhood 
malignancies. They also reported an association between 
lymphoma and poor living standards, as well as a lower 
incidence of lymphomas and higher incidence of leukae-
mia than previously reported from other parts of Niger a 
and Africa7. Our study findings suggest a relative reduc-
tion in the proportions of lymphoma and leukaemia, and 
an associated increase in the proportions of nephroblas-
toma and rhabdomyosarcoma among childhood and ado-
lescent malignancies in this environment. Improved di-
agnostic facilities, greater number of trained health 
workers, improved living conditions and an increased 
parental awareness about childhood malignancies result-
ing in a wider variety of cases presenting in hospitals, 
may all account for changes in disease pattern within the 
region over the years. Our study finding are also at vari-
ance with those from the United States were leukaemi
(30.2%), CNS cancers (21.7%) and lymphoma (10.9%) 
are the commonest childhoodmalignancies15, possibly 
also due to the aforementioned factors, especially better 
living conditions. The pattern of childhood cancer in 
Europe is reportedly similar to that in the United States1. 
 
The lymphoma group showed equal gender ratio, and 
equal proportions seen below and above the age of 10 
years. However, below 10 years of age, lymphomas pre-
dominantly occurred between 5 -9years, which is in 
agreement with study findings in Bangladesh by Jabeen 
et al1. Leukaemia on the other hand was diagnosed more 
among males than females in the ratio of 3:2, with the 
largest affected group aged 5 – 9years. This is at vari-
ance with findings in Bradford by Mckinney10 and in 
Bangladesh byJabeen1 who both reported leukaemia as 
most common under age of 5 years. This difference may
be due to delayed case presentation among the Nigerian 
study population, as well as differences in the forms of 
leukaemia that may be prevalent at different age groups 
in the UK, Bangladesh and Nigeria. Nephroblastoma 
was more common in boys (M:F = 6:4) and occurred 
exclusively among individuals below the age of 10 
years, with peak age at 0 – 4 years. This is consistent 
with sprevious literature on the disease17, 18. The rhabdo-
myosarcoma group was separated from other soft tissue 
sarcomas due to their high relative frequency of occur-
rence. They are most commonly seen at 5 - 9 years of 
age, and show a wide difference in gender ratio (M:F = 
7:3). The group of soft tissue sarcomas in exclusion of 
rhabdomyosarcomas constitute 3.35% of childhood ma-
lignancies, affecting more males than females (2:1) and 
more prevalent in adolescents (10 – 18years). Adigun et 
al19 at Ilorin, Nigeria, reported soft tissue sarcomas in-
cluding rhabdomyosarcoma as infrequent, accounting 
for 6.5% of all cancers in children aged 0 - 15 years. 
However, Tanko et al8 at Jos, Nigeria, reported rhabdo-
myosarcoma as the commonest childhood malignancy 
(31%), exceeding non-Hodgkin (19.5%) and Burkitt 
lymphoma (13.8%).Various environmental influences, 
diet and cultural habits, as well as public awareness 
about childhood malignancies may all account for the
suggested variation in the incidence of soft tissue ar-
coma in the different regions of Nigeria. In this study, 
retinoblastoma was the 5th commonest malignancy 
(5.88%), seen exclusively in children aged 0 – 4 years 
with a gender ratio of 3:2 in favour of females. Our find-
ing is partly similar to that of Jabeen et al1 in Bangla-
desh who reported 70% of Retinoblastoma occurring 
below the age of 5 years and second only to lymphoma 
among childhood malignancies. Agboola et al16 also 
reported Retinoblastoma (21%) as second only to lym-
phoma among children diagnosed with malignancies at 
Shagamu, Nigeria. A future population based study in 
south-east Nigeria may be needed to determine the ac-
tual regional prevalence of retinoblastoma. Ovarian ma-
lignancies (4.71%) occurred equally among females 
aged above and below the age of10 years. This is in par-
tial agreement with the study report by Junaid 20 who 
also described ovarian tumours as relatively uncommn, 
with larger proportion occurring at 10 years and above 
among children aged 0 – 20 years in south-west Nigeria. 
Osteogenic sarcoma (3.35%) occurred exclusively in 
children aged 12 - 18 years, with median age of 14 years 
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and a gender ratio of 2:1 in favour of males. Parkin 
etal21 had earlier put bone tumours at 5% of all child-
hood malignancies worldwide, with  osteogenic sarcoma 
comprising a large proportion of this.  
 
Numerous histological and cytological entities not indi-
vidually mentioned in this text are relatively few as indi-
vidual cases and are grouped as ‘Others’. They colle -
tively constitute 35.29% of the study population, ad 
considered individually as rare in our environment (see 
footnotes). The CNS tumours are not featured in this
study, possibly due to a dearth of relevant facilities for 
proper overall neuro-paediatric diagnosis and clinial 





Findings from this hospital based study suggest tha
lymphoma, leukaemia, rhabdomyosarcoma and nephro-
blastoma are the commonest malignancies afflicting 
children and adolescents in the south-east region of  
Nigeria. 
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